Cost and cost-effectiveness in a randomized trial of long-acting risperidone for schizophrenia
- PMID: 23140655
- DOI: 10.4088/JCP.12lr07934
Cost and cost-effectiveness in a randomized trial of long-acting risperidone for schizophrenia
Comment on
-
Cost and cost-effectiveness in a randomized trial of long-acting risperidone for schizophrenia.J Clin Psychiatry. 2012 May;73(5):696-702. doi: 10.4088/JCP.11m07070. J Clin Psychiatry. 2012. PMID: 22697193 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical